Clinical Trials
19
Active:0
Completed:11
Trial Phases
4 Phases
Phase 2:2
Phase 3:3
Phase 4:4
+1 more phases
Drug Approvals
4
FDA:4
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (52.6%)Phase 4
4 (21.1%)Phase 3
3 (15.8%)Phase 2
2 (10.5%)Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Primus Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT06382662
- Locations
- 🇺🇸
Sun Valley Arthritis Center, Peoria, Arizona, United States
Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg
Phase 4
Recruiting
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Primus Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT06348303
- Locations
- 🇺🇸
ClinOhio Research Institute, Columbus, Ohio, United States
Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
Not Applicable
Recruiting
- Conditions
- Digital UlcerScleroderma, Systemic
- First Posted Date
- 2024-02-13
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Primus Pharmaceuticals
- Target Recruit Count
- 45
- Registration Number
- NCT06256575
- Locations
- 🇨🇦
Saint Joseph Health Care Centre, London, Ontario, Canada
🇨🇦Mount Sinai Health System, Toronto, Ontario, Canada
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Phase 4
Recruiting
- Conditions
- Sciatica AcuteLumbar Spinal Stenosis
- Interventions
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Primus Pharmaceuticals
- Target Recruit Count
- 50
- Registration Number
- NCT06157177
- Locations
- 🇺🇸
East Alabama Arthritis Center, Auburn, Alabama, United States
🇺🇸Sean Wollaston, MD, Valley Village, California, United States
🇺🇸Arthritis and Osteoporosis Center, Aventura, Florida, United States
Vasculera in Participants With Lipedema
Not Applicable
Completed
- Conditions
- Lipedema
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Primus Pharmaceuticals
- Target Recruit Count
- 34
- Registration Number
- NCT05616962
- Locations
- 🇺🇸
Primus Pharmaceuticals, Scottsdale, Arizona, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found